Sugammadex Versus Neostigmine for Antagonism of Rocuronium-induced Neuromuscular Blockade in Patients With Liver Cirrhosis Undergoing Liver Resection: A Controlled Randomized Study

Trial Profile

Sugammadex Versus Neostigmine for Antagonism of Rocuronium-induced Neuromuscular Blockade in Patients With Liver Cirrhosis Undergoing Liver Resection: A Controlled Randomized Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Sep 2016

At a glance

  • Drugs Sugammadex (Primary) ; Neostigmine; Rocuronium bromide
  • Indications Neuromuscular blockade
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 16 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top